We are live on ! Find out more
SGMO

SANGAMO THERAPEUTICS INC
SGMO

Delisted

SGMO was delisted on the 4th of May, 2026.

Back to rankings

210 hedge funds and large institutions have $767M invested in SANGAMO THERAPEUTICS INC in 2020 Q3 according to their latest regulatory filings, with 32 funds opening new positions, 55 increasing their positions, 69 reducing their positions, and 25 closing their positions.

New
Increased
Maintained
Reduced
Closed

29% more call options, than puts

Call options by funds: $14.1M | Put options by funds: $11M

28% more first-time investments, than exits

New positions opened: 32 | Existing positions closed: 25

11% more capital invested

Capital invested by funds: $691M → $767M (+$76.4M)

3.17% more ownership

Funds ownership: 54.73% → 57.9% (+3.2%)

2% more funds holding

Funds holding: 205 → 210 (+5)

20% less repeat investments, than reductions

Existing positions increased: 55 | Existing positions reduced: 69

Holders
210
Holders Change
+5
Holders Change %
+2.44%
% of All Funds
4.24%
Holding in Top 10
1
Holding in Top 10 Change
+1
Holding in Top 10 Change %
% of All Funds
0.02%
New
32
Increased
55
Reduced
69
Closed
25
Calls
$14.1M
Puts
$11M
Net Calls
+$3.14M
Net Calls Change
-$1.82M

Top Buyers

Rank Fund Capital Flow
1
Renaissance Technologies
Renaissance Technologies
New York
+$14.3M
2
Citadel Advisors
Citadel Advisors
Florida
+$10.7M
3
N
Nuveen
North Carolina
+$7.17M
4
Invesco
Invesco
Georgia
+$6.08M
5
Millennium Management
Millennium Management
New York
+$5.96M

Top Sellers

Rank Fund Capital Flow
1
BlackRock
BlackRock
New York
-$4.91M
2
CC
Casdin Capital
New York
-$4.06M
3
Two Sigma Investments
Two Sigma Investments
New York
-$3.74M
4
Vanguard Group
Vanguard Group
Pennsylvania
-$3.74M
5
Nordea Investment Management
Nordea Investment Management
Sweden
-$3.54M
Name Holding Trade Value Shares
Change 		Change in
Stake
Fifth Third Bancorp
201
Fifth Third Bancorp
Ohio
$1K – – –
GWM
202
Geneos Wealth Management
Colorado
$1K – – –
OSAM
203
O'Shaughnessy Asset Management
Connecticut
$1K – – –
PA
204
Parallel Advisors
California
$1K – – –
VFA
205
Valeo Financial Advisors
Indiana
$1K – – –
IA
206
IFP Advisors
Florida
$1K +$519 +48 +31%
ECM
207
Estabrook Capital Management
New York
$132 – – –
State of New Jersey Common Pension Fund D
208
State of New Jersey Common Pension Fund D
New Jersey
– -$1.7M -189,643 Closed
TCM
209
Tekla Capital Management
Massachusetts
– -$1.34M -149,835 Closed
SM
210
Senvest Management
New York
– -$836K -93,258 Closed
QIM
211
Quantitative Investment Management
Virginia
– -$771K -86,145 Closed
MWNA
212
Marshall Wace North America
New York
– -$751K -83,826 Closed
BCM
213
Bayesian Capital Management
New York
– -$481K -53,700 Closed
FAAS
214
First Allied Advisory Services
California
– -$413K -46,100 Closed
HSBC Holdings
215
HSBC Holdings
United Kingdom
– -$395K -44,086 Closed
Voloridge Investment Management
216
Voloridge Investment Management
Florida
– -$345K -38,454 Closed
NIT
217
NumerixS Investment Technologies
British Columbia, Canada
– -$331K -36,894 Closed
DTL
218
Dynamic Technology Lab
Singapore
– -$176K -19,628 Closed
HS
219
Haafor (Singapore)
Singapore
– -$113K -12,659 Closed
IFG
220
Investors Financial Group
Minnesota
– -$99K -11,000 Closed
GCP
221
GSA Capital Partners
United Kingdom
– -$92K -10,223 Closed
Ensign Peak Advisors
222
Ensign Peak Advisors
Utah
– -$60K -6,658 Closed
PAG
223
Private Advisor Group
New Jersey
– -$56K -6,200 Closed
FDCDDQ
224
Federation des caisses Desjardins du Quebec
Quebec, Canada
– -$52K -5,800 Closed
PFGIA
225
Patriot Financial Group Insurance Agency
Massachusetts
– -$45K -5,000 Closed
6 7 8
9
10

SGMO Hedge Fund Activity: Q3 2020 in Review

210 of the 4,957 institutional investors tracked by Wall St. Rank reported a position in SANGAMO THERAPEUTICS INC (SGMO) for Q3 2020, worth a combined $767M — up 11% from $691M a quarter earlier.

Buyers outnumbered sellers: 32 funds opened new SGMO positions and 25 closed out — a net gain of 7 holders — while 55 added to existing stakes and 69 trimmed.

The largest buyer was Renaissance Technologies, opening a new position worth an estimated $14.3M. The largest seller was BlackRock, cutting an estimated $4.91M.

  • 210 institutional investors held SANGAMO THERAPEUTICS INC (SGMO) as of Q3 2020, up from 205 in Q2 2020.
  • Funds reported $767M of SANGAMO THERAPEUTICS INC stock for Q3 2020, up 11% quarter-over-quarter.
  • 32 funds opened new SANGAMO THERAPEUTICS INC positions in Q3 2020 and 25 closed out, a net change of +7 holders.
  • The largest SANGAMO THERAPEUTICS INC buyer in Q3 2020 was Renaissance Technologies, an estimated $14.3M added.
  • The largest SANGAMO THERAPEUTICS INC seller in Q3 2020 was BlackRock, an estimated $4.91M sold.

Based on aggregated 13F filings for Q3 2020.